Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidobacteria Mixture in Pediatric FGIDs
NCT02566876Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Dec 2013
- Primary completion
- Jul 2015
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
A Phase 4 trial of Bifidobacterium longum BB536, bifidobacterium longum subsp. infantis m-63, bifidobacterium breve M-16V in irritable bowel syndrome (IBS), functional dyspepsia (FD), sponsored by University of Naples Federico II. Started Dec 2013; status: completed.
02
Drugs
Bifidobacterium longum BB536bifidobacterium longum subsp. infantis m-63bifidobacterium breve M-16V
03
Conditions
irritable bowel syndrome (IBS)functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02566876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566876.